Dow Up0.08% Nasdaq Down0.30%

Tetraphase Pharmaceuticals, Inc. (TTPH)

17.73 Up 0.06(0.34%) Sep 19, 4:00PM EDT
ProfileGet Profile for:
Tetraphase Pharmaceuticals, Inc.
480 Arsenal Street
Suite 110
Watertown, MA 02472
United States - Map
Phone: 617-715-3600
Fax: 617-926-3557

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:46

Business Summary 

Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections. Its lead product candidate is eravacycline, an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of multidrug-resistant infections, including multidrug-resistant Gram-negative bacteria. The company is conducting a Phase III clinical trial of eravacycline with intravenous administration for the treatment of complicated intra-abdominal infections; and a second Phase III clinical trial of eravacycline for the treatment of complicated urinary tract infections with intravenous-to-oral step-down therapy. It is also developing TP-271, a preclinical compound for respiratory diseases caused by bacterial biothreat pathogens; and preclinical Gram-negative program for multidrug-resistant Gram-negative infections. The company was founded in 2006 and is headquartered in Watertown, Massachusetts.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Tetraphase Pharmaceuticals, Inc.

Corporate Governance 
Tetraphase Pharmaceuticals, Inc.’s ISS Governance QuickScore as of Sep 1, 2014 is 6. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 8; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Guy MacDonald B.Sc, 55
Chief Exec. Officer, Pres and Director
Mr. David C. Lubner CPA, 50
Chief Financial Officer, Principal Accounting Officer and Sr. VP
Dr. Patrick T. Horn M.D., Ph.D., 59
Chief Medical Officer
Mr. John Craig Thompson , 47
Chief Operating Officer
Dr. Joyce Sutcliffe Ph.D., 62
Sr. VP of Biology
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders